Shimony, Shai http://orcid.org/0000-0001-7245-9652
Bewersdorf, Jan Philipp http://orcid.org/0000-0003-3352-0902
Shallis, Rory M. http://orcid.org/0000-0002-8542-2944
Liu, Yiwen
Schaefer, Eva J.
Zeidan, Amer M.
Goldberg, Aaron D.
Stein, Eytan M.
Marcucci, Guido http://orcid.org/0000-0002-3983-5908
Lindsley, R. Coleman
Chen, Evan C.
Ramos Perez, Jorge
Stein, Anthony
DeAngelo, Daniel J. http://orcid.org/0000-0001-7865-2306
Neuberg, Donna S. http://orcid.org/0000-0003-2566-3145
Stone, Richard M. http://orcid.org/0000-0002-7526-2633
Ball, Brian
Stahl, Maximilian
Article History
Received: 15 December 2023
Revised: 2 February 2024
Accepted: 6 February 2024
First Online: 20 February 2024
Competing interests
: SS, JPB, YL, EJS, GM, JRP, and BB have no disclosure. RMS (Yale) reports consultancy for BMS, Curio Science, Gilead, Servier, Rigel. AMZ reports consultancy and Honoraria for Abbvie, Pfizer, Celgene/BMS, Jazz, Incite, Agios, Servier, Boehringer-Ingelheim, Novartis, Astellas, Daiichi Sankyo, Geron, Taiho, Seattle Genetics, Otsuka, BeyondSpring, Takeda, Ionis, Amgen, Janssen, Genentech, Epizyme, Syndax, Gilead, Kura, Chiesi, ALX Oncology, BioCryst, Notable, Orum, Mendus, Zentalis, Schrodinger, Regeneron, Tyme. ADG reports Consultancy for Abbvie, Astellas, Daiichi Sankyo, Genentech; Research funding from Abbvie, Aprea, Aptose, Arog, Celularity, Pfizer, Prelude; Honoraria from Dava Oncology. EMS reports consultancy for Abbvie, Agios, Aptose, Astellas, Blueprint, BMS, Calithera, CTI, DSI, Foghorn Therapeutics, Genentech, Genesis, Gilead, Janssen, Jazz, Menarini, Neoleukin, Novartis, Oncusp, Ono Pharma, PinotBio, Servier, Syndax, Syros, Cellectis, Epizyme, Kura; Research funding from Eisai, BMS; Current equity holder publicly traded company – Auron therapeutics. ECC reports research funding from Abbvie; Consultancy and Honoraria for Rigel Pharmaceuticals. RCL reports consultancy for Takeda Pharmaceuticals, Bluebird bio, Qiagen, Sarepa Therapeutics, Verve Therapeutics, Jazz Pharmaceuticals, Vertex Pharmaceuticals; Membership on board of directors in Bluebird bio. AS reports Current Employment and Current holder of stock options at Sanofi. DJD reports consultancy for Amgen, Autolus, Blueprint, Gilead, Incyte, Jazz, Kite, Novartis, Pfizer, Servier, and Takeda; received research funding from Abbvie, Novartis, Blueprint and Glycomimetrics. DSN reports equity holder in Madrigal Pharmaceuticals. RMS reports consultancy for Abbvie, CTI Biopharma, GSK, Hermavant, Ligand Pharma, Lava Therapeutics, Amgen, AvenCell, BerGenBio, Cellularity, Jazz, Kura One, Rigel Pharmaecuticals. Serves on safety committee members in Aptevo, Epizyme, Takeda, and Syntrix. MS reports consultancy and serves as a member of the board of directors in Kymera, GSK, and Rigel Pharmaceuticals.